A Phase II clinical trial to assess mesenchymal adult stem cells as a disease-modifying therapy for Parkinson’s disease has been launched at The University of Texas Health Science Center at Houston
[The University of Texas Health Science Center at Houston (Newswise, Inc.)]
6445218
{6445218:nan}
apa
50
1
161352
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
